NEW YORK, Sept. 18 (GenomeWeb News) - 454 Life Sciences has raised $20 million from parent company CuraGen and from existing shareholder Cooper Hill Partners to help it commercialize its whole genome-sequencing technology, 454 said today.
Already have a GenomeWeb or 360Dx account?Login Now.
A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.
A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.
Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.
In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.